These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28480535)

  • 1. Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.
    Pollock J; Coffman J; Ho SV; Farid SS
    Biotechnol Prog; 2017 Jul; 33(4):854-866. PubMed ID: 28480535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
    Pollock J; Ho SV; Farid SS
    Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-to-end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies.
    Mahal H; Branton H; Farid SS
    Biotechnol Bioeng; 2021 Sep; 118(9):3468-3485. PubMed ID: 33792918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture.
    Pollock J; Bolton G; Coffman J; Ho SV; Bracewell DG; Farid SS
    J Chromatogr A; 2013 Apr; 1284():17-27. PubMed ID: 23453463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating end-to-end continuous antibody manufacture with column-free capture alternatives from economic, environmental, and robustness perspectives.
    Neves CPG; Coffman JL; Farid SS
    Biotechnol Prog; 2024; 40(4):e3427. PubMed ID: 38289674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreactor productivity and media cost comparison for different intensified cell culture processes.
    Xu S; Gavin J; Jiang R; Chen H
    Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economics and ecology: Modelling of continuous primary recovery and capture scenarios for recombinant antibody production.
    Cataldo AL; Burgstaller D; Hribar G; Jungbauer A; Satzer P
    J Biotechnol; 2020 Jan; 308():87-95. PubMed ID: 31809781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-cycle and cost of goods assessment of fed-batch and perfusion-based manufacturing processes for mAbs.
    Bunnak P; Allmendinger R; Ramasamy SV; Lettieri P; Titchener-Hooker NJ
    Biotechnol Prog; 2016 Sep; 32(5):1324-1335. PubMed ID: 27390260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic assessment of continuous processing for manufacturing of biotherapeutics.
    Gupta P; Kateja N; Mishra S; Kaur H; Rathore AS
    Biotechnol Prog; 2021 Mar; 37(2):e3108. PubMed ID: 33305493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.
    Arnold L; Lee K; Rucker-Pezzini J; Lee JH
    Biotechnol J; 2019 Feb; 14(2):e1800061. PubMed ID: 29729129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity planning for batch and perfusion bioprocesses across multiple biopharmaceutical facilities.
    Siganporia CC; Ghosh S; Daszkowski T; Papageorgiou LG; Farid SS
    Biotechnol Prog; 2014; 30(3):594-606. PubMed ID: 24376262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.
    Xu J; Xu X; Huang C; Angelo J; Oliveira CL; Xu M; Xu X; Temel D; Ding J; Ghose S; Borys MC; Li ZJ
    MAbs; 2020 Jan; 12(1):1770669. PubMed ID: 32425110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production.
    Steinebach F; Müller-Späth T; Morbidelli M
    Biotechnol J; 2016 Sep; 11(9):1126-41. PubMed ID: 27376629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process development and characterization for integrated continuous bioprocesses-Highlights from N-mAb.
    Brower K; Wiltberger K; Berdugo C; Bosley A; Goodrich E; Pferdeort V; Schaefer G
    Biotechnol Prog; 2024; 40(4):e3425. PubMed ID: 38289271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process economics of industrial monoclonal antibody manufacture.
    Farid SS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):8-18. PubMed ID: 16899415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro-bioreactor system.
    Velugula-Yellela SR; Williams A; Trunfio N; Hsu CJ; Chavez B; Yoon S; Agarabi C
    Biotechnol Prog; 2018 Jan; 34(1):262-270. PubMed ID: 29086492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity.
    Kamga MH; Cattaneo M; Yoon S
    Prep Biochem Biotechnol; 2018 May; 48(5):383-390. PubMed ID: 29509101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
    Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
    Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.